(Q43651415)

25 November 2017

title

Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure (English)

1 reference

25 November 2017

main subject

congestive heart failure

1 reference

Nasser A

1

1 reference

25 November 2017

Dietz JR

2

1 reference

25 November 2017

Siddique M

3

1 reference

25 November 2017

Patel H

4

1 reference

25 November 2017

Khan N

5

1 reference

25 November 2017

Antwi EK

6

1 reference

25 November 2017

San Miguel GI

7

1 reference

25 November 2017

McCormick MT

8

1 reference

25 November 2017

Schocken DD

9

1 reference

25 November 2017

Vesely DL

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Cardiology

25 November 2017

published in

1 reference

25 November 2017

volume

88

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

23-29

1 reference

Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Change in plasma immunoreactive N-terminus, C-terminus, and 4,000-dalton midportion of atrial natriuretic factor prohormone with hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Increased Release of the N-Terminal and C-Terminal Portions of the Atrial Natriuretic Factor Prohormone during Immersion-Induced Central Hypervolemia in Cirrhotic Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic peptide fragments in dogs with experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Lack of inhibition of vasopressin-stimulated NA+K+ATPase by atrial natriuretic factor in the rat renal medullary thick ascending limb of Henle's loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

10.1016/S0002-9149(01)01579-X

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference